Manja Boerman

Manja Boerman has over 25 years of experience in the biopharmaceutical industry with a deep specialization in protein, cell and gene therapy.  Manja’s career highlights include President of Catalent Protein, Cell and Gene Therapy, Aesica Pharmaceuticals, Patheon Biologics, and DSM Biologics, as well as CEO of Kiadis Pharma and Regenesance. 

Manja holds a board positions at Syngene International Ltd. where she is a member of the Risk Management Committee, Science and Technology Committee and the Stakeholders Relationship & ESG Committee.  She also holds a board position at Dinamiqs, a Siegfried company. 

Manja has a PhD in Biochemistry from the State University of New York, reflecting her strong academic background in life sciences.